Interacting Drugs |
Lidocaine (systemic) vs Fesoterodine |
Security Level |
 |
Mechanism |
Fesoterodine: CYP2D6 Inhibitors may increase serum concentrations of the active metabolite(s) of Fesoterodine. |
Management |
Monitor therapy |
Lidocaine (systemic) vs Fesoterodine
Post Review about Lidocaine (systemic) vs Fesoterodine Click here to cancel reply.
Other Interactions of Lidocaine (systemic)
Other Interactions of Fesoterodine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.